$-1.18
(Market cap
$29,083 Mln
Revenue (TTM)
$4,818 Mln
P/E Ratio
32.3
P/B Ratio
9.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.4 %
-
ROCE
19 %
-
Industry P/E
50.52
-
EV/EBITDA
18.9
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$2.3
-
Face value
--
-
Shares outstanding
385,872,977
10 Years Aggregate
CFO
$2,994.60 Mln
EBITDA
$1,895.00 Mln
Net Profit
$1,309.20 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DexCom (DXCM)
| 11.8 | 28.3 | 15.5 | -9.5 | -16.4 | -6.2 | 15.0 |
|
BSE Sensex
| -9.9 | 1.1 | 2.3 | -6.0 | 6.4 | 7.7 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
DexCom (DXCM)
| -14.7 | -37.1 | 9.6 | -15.6 | 45.2 | 69.0 | 82.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DexCom (DXCM)
|
74.2 | 29,083.3 | 4,817.9 | 930.4 | 25.3 | 32.7 | 32.3 | 9.8 |
| 88.7 | 153,593.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.7 | 3.0 | |
| 46.8 | 70,111.4 | 20,615.0 | 3,553.0 | 19.9 | 14.5 | 19.7 | 2.8 | |
| 181.1 | 127,957.8 | 24,778.0 | 3,689.0 | 18.5 | 7.1 | 35.1 | 2.4 | |
| 86.3 | 49,006.3 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46 | 4.8 | |
| 570.0 | 44,243.9 | 4,446.1 | 1,095.2 | 31.7 | 70.3 | 41.3 | 28.4 | |
| 416.6 | 145,582.2 | 10,582.1 | 2,979.1 | 25.0 | 17.2 | 50 | 8.3 | |
| 80.4 | 103,134.5 | 36,364.0 | 4,800.0 | 13.3 | 19.6 | 21.5 | 2.1 | |
| 307.9 | 117,170.4 | 25,270.0 | 3,337.0 | 18.7 | 15.1 | 35.3 | 5.1 | |
| 473.7 | 176,765.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 26.2 | 3.4 |
Shareholding Pattern
View DetailsAbout DexCom (DXCM)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company... offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Read more
-
Executive Chairman, CEO & President
Mr. Kevin Ronald Sayer
-
Executive Chairman, CEO & President
Mr. Kevin Ronald Sayer
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for DexCom (DXCM)
What is the current share price of DexCom Inc (DXCM) Today?
The share price of DexCom Inc (DXCM) is $74.19 (NASDAQ) as of 15-Jun-2026 16:15 EDT. DexCom Inc (DXCM) has given a return of -16.42% in the last 3 years.
What is the current PB & PE ratio of DexCom Inc (DXCM)?
The P/E ratio of DexCom Inc (DXCM) is 32.35 times as on 12-Jun-2026, a 36 discount to its peers’ median range of 50.52 times.
The P/B ratio of DexCom Inc (DXCM) is 9.82 times as on 12-Jun-2026, a 191 premium to its peers’ median range of 3.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
31.66
|
9.64
|
|
2024
|
54.89
|
15.04
|
|
2023
|
95.31
|
24.95
|
|
2022
|
141.35
|
22.62
|
|
2021
|
960.52
|
102.02
|
What is the 52 Week High and Low of DexCom Inc (DXCM)?
The 52-week high and low of DexCom Inc (DXCM) are Rs 89.98 and Rs 54.11 as of 16-Jun-2026.
What is the market cap of DexCom Inc (DXCM)?
DexCom Inc (DXCM) has a market capitalisation of $ 29,083 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in DexCom Inc (DXCM)?
Before investing in DexCom Inc (DXCM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.